Posted on Wednesday 2 December 2020 by Adam Simmonds | Investment Research Analyst
The past couple of weeks have been littered with announcement after announcement about vaccines, Pfizer & BioNTech, Moderna, and Oxford University & AstraZeneca. All have been featuring in the news with their promising results that are potentially paving the way for a return to normality.
> Read more
What did the Chancellor announce in the 2023 Autumn Statement?
What to look out for at next week’s Autumn Statement – November 2023
GovGrant expands Accounting Channel team to meet the increased demand of specialist R&D services
Being a Source Advisors company – what does it mean for our accounting partners
HMRC releases R&D tax relief and Patent Box statistics 2023
